Northern Trust Corp Rapt Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 242,501 shares of RAPT stock, worth $259,476. This represents 0.0% of its overall portfolio holdings.

Number of Shares

242,501

Previous 275,163 11.87%

Holding current value

$259,476

Previous $839,000 41.95%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.76 - $3.75 $57,485 - $122,482	-32,662 Reduced 11.87%	242,501 $487,000
Q2 2024 Aug 14, 2024	SELL	$2.89 - $9.38 $61,528 - $199,700	-21,290 Reduced 7.18%	275,163 $839,000
Q1 2024 May 14, 2024	SELL	$6.87 - $26.45 $58,628 - $225,724	-8,534 Reduced 2.8%	296,453 $2.66 Million
Q4 2023 Feb 13, 2024	BUY	$11.28 - $25.46 $82,253 - $185,654	7,292 Added 2.45%	304,987 $7.58 Million
Q3 2023 Nov 13, 2023	BUY	$16.34 - $24.66 $165,720 - $250,101	10,142 Added 3.53%	297,695 $4.95 Million
Q2 2023 Aug 11, 2023	BUY	$16.06 - $21.61 $15,722 - $21,156	979 Added 0.34%	287,553 $5.38 Million
Q1 2023 May 15, 2023	BUY	$17.19 - $30.8 $608,233 - $1.09 Million	35,383 Added 14.09%	286,574 $5.26 Million
Q4 2022 Feb 13, 2023	BUY	$16.28 - $24.6 $43,874 - $66,297	2,695 Added 1.08%	251,191 $4.97 Million
Q3 2022 Nov 14, 2022	BUY	$17.96 - $30.46 $54,329 - $92,141	3,025 Added 1.23%	248,496 $5.98 Million
Q2 2022 Aug 12, 2022	BUY	$10.26 - $23.59 $343,114 - $788,896	33,442 Added 15.77%	245,471 $4.48 Million
Q1 2022 May 13, 2022	SELL	$17.02 - $40.22 $45,392 - $107,266	-2,667 Reduced 1.24%	212,029 $4.66 Million
Q4 2021 Feb 08, 2022	SELL	$29.5 - $39.5 $73,809 - $98,829	-2,502 Reduced 1.15%	214,696 $7.89 Million
Q3 2021 Nov 15, 2021	BUY	$29.86 - $39.47 $940,739 - $1.24 Million	31,505 Added 16.97%	217,198 $6.75 Million
Q2 2021 Aug 13, 2021	BUY	$17.99 - $40.02 $886,367 - $1.97 Million	49,270 Added 36.12%	185,693 $5.9 Million
Q1 2021 May 12, 2021	SELL	$16.0 - $24.46 $229,920 - $351,490	-14,370 Reduced 9.53%	136,423 $3.03 Million
Q4 2020 Feb 11, 2021	BUY	$15.89 - $40.87 $37,309 - $95,962	2,348 Added 1.58%	150,793 $2.98 Million
Q3 2020 Nov 16, 2020	SELL	$21.6 - $37.5 $13,564 - $23,550	-628 Reduced 0.42%	148,445 $4.78 Million
Q2 2020 Aug 14, 2020	BUY	$14.16 - $32.85 $1.64 Million - $3.81 Million	115,963 Added 350.24%	149,073 $4.33 Million
Q1 2020 May 14, 2020	BUY	$11.86 - $48.86 $216,456 - $891,743	18,251 Added 122.83%	33,110 $705,000
Q4 2019 Feb 14, 2020	BUY	$12.3 - $30.78 $182,765 - $457,360	14,859 New	14,859 $410,000

Others Institutions Holding RAPT

# of Institutions

104

Shares Held

27.1M

Call Options Held

26.7K

Put Options Held

2.4K

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $31.7M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Rapt Therapeutics, Inc. Transaction History